+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

OC29.02: Serum YKL-40a potential new biomarker for preeclampsia and intrauterine growth restriction



OC29.02: Serum YKL-40a potential new biomarker for preeclampsia and intrauterine growth restriction



Ultrasound in Obstetrics & Gynecology 34(S1): 56-56




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063823733

Download citation: RISBibTeXText

DOI: 10.1002/uog.6628


Related references

Umbilical cord blood concentrations of nitric oxide metabolites are higher in preeclampsia with intrauterine growth restriction, but not in preeclampsia or intrauterine growth restriction alone. American Journal of Obstetrics & Gynecology 180(1 Part 2): S44, 1999

OC29.04: Assessment of aorta intima media thickness in intrauterine growth restriction: evaluation from fetal to neonatal life. Ultrasound in Obstetrics & Gynecology 34(S1): 56-57, 2009

Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction?. Acta Obstetricia et Gynecologica Scandinavica 81(6): 540-543, 2002

OC29.05: Hypertension and renal dysfunction in infants with intrauterine growth restriction: the role of aorta intima media thickness before and after birth. Ultrasound in Obstetrics & Gynecology 34(S1): 57-57, 2009

Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagnosis and Therapy 20(1): 48-53, 2004

Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia. Journal of Perinatal Medicine 44(3): 269-275, 2017

The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction. Journal of Maternal-Fetal and Neonatal Medicine 28(1): 26-32, 2016

Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction. Hypertension in Pregnancy 32(1): 83-93, 2014

Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction. Journal of Perinatal Medicine 45(7): 793-802, 2016

Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key. Placenta 28(2-3): 224-232, 2006

Combining 2nd-trimester maternal serum homocysteine levels and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction. Gynecologic and Obstetric Investigation 61(3): 142-148, 2005

Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatric Research 54(1): 20-25, 2003

A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction. Plos One 11(10): E0165060, 2016

Evaluation of normalization of cerebro-placental ratio as a potential predictor for adverse outcome in SGA fetuses. American Journal of Obstetrics and Gynecology 216(3): 285.E1-285.E6, 2016

Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study. Plos One 12(3): E0174399, 2017